India Begs Novartis To Drop Patent Challenge

Law360, New York (April 10, 2007, 12:00 AM EDT) -- India’s health minister is calling for Novartis AG to back down from its controversial legal battle to patent Gleevec in the country, reportedly arguing that the Swiss drug maker’s challenge to a key section of India’s patent laws could block global access to affordable drugs.

Union Health Minister Anbumani Ramadoss urged Novartis to withdraw its patent challenge, stating that he is “very concerned” that the outcome of the lawsuit could affect the global supply of cheap AIDS drugs, Reuters reported Tuesday.

Ramadoss added that if Novartis...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.